1Calverley PM,Anderson JA,Celli B,et al.Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease[J].N Engl J Med,2007,356(8):775-789.
2Kardos P,Wencker M,Glaab T,et al.Impact of salmeterol/ fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2007,175(2):144-149.
3Wedzicha JA,Calverley PM,Seemungal TA,et al.The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide[J].Am J Respir Crit Care Med,2008,177(1):19-26.
4Ernst P,Gonzalez AV,Brassard P,et al.Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia[J].Am J Respir Crit Care Med,2007,176(2):162-166.
5Drummond MB,Dasenbrook EC,Pitz MW,et al.Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease:a systematic review and meta-analysis[J].JAMA,2008,300(20):2407-2016.
6Sin DD,Tashkin D,Zhang X,et al.Budesonide and the risk of pneumonia:a meta-analysis of individual patient data[J].Lancet,2009,374(9691):712-719.
7Welte T,Kohnlein T.Global and local epidemiology of community-acquired pneumonia:the experience of the CAPNETZ Network[J].Semin Respir Crit Care Med,2009,30(2):127-135.
